This is a working overview of molecular weight, written for readers who want more than a one-paragraph summary but less than a textbook.
This page was last updated on 2026-02-11 and is reviewed periodically as new material appears.
Regulatory treatment of collagen peptides varies by country and intended use. In the United States, they are typically marketed as dietary supplements or food ingredients, and certain uses may be generally recognized as safe (GRAS) through self-affirmation or notification. In the European Union, collagen peptides from approved animal sources are considered food, not novel foods, if they have a history of consumption. Health claims linking collagen peptides to joint or skin benefits are not approved in the US or EU. Labeling must list the animal source and may state the protein content.
Manufacturing collagen peptides begins with collagen-rich raw materials such as bovine hide, porcine skin, fish scales, or poultry cartilage, which undergo washing, size reduction, and pretreatment to remove non-collagen proteins and fats. Extraction may use acid, alkali, or heat. Hydrolysis then breaks the collagen into smaller peptides, often with enzymes such as pepsin, papain, or alcalase. Process conditions of time, temperature, pH, and enzyme dose determine the final molecular weight distribution. After hydrolysis, the solution is filtered, concentrated, and dried into powder.
Quality control for collagen peptides may include identity, purity, and contaminant testing. Identity can be supported by amino acid profile and hydroxyproline content; purity checks may examine moisture, ash, protein content, and peptide size range. Heavy metals, microbial counts, and residual solvents are relevant for materials intended for ingestion. Some suppliers use peptide fingerprinting or source-specific markers, though these methods are not universally standardized. Documentation such as certificates of analysis helps verify that a batch meets agreed specifications.
Analytical characterization of collagen peptides often begins with peptide size distribution. Size-exclusion chromatography can separate peptides by hydrodynamic volume, while mass spectrometry provides more detailed mass information. Amino acid analysis quantifies residues such as glycine, proline, and hydroxyproline. Hydroxyproline assays are widely used because this amino acid is uncommon in many other proteins; nitrogen content and ash values help assess purity and residual minerals. No single method captures all relevant properties, so laboratories commonly combine several techniques.
Stability depends on moisture, temperature, oxygen, and packaging. Dry collagen peptide powders are generally stable when kept cool and dry, but humid conditions can cause clumping and microbial growth. Heat exposure may promote Maillard reactions if reducing sugars are present, altering color and flavor. Solutions are less stable than powders and may support microbial proliferation unless preserved or refrigerated; light exposure can also affect appearance over time. Shelf-life claims vary and should be supported by real-time or accelerated stability data.
| Property | Value | Notes |
|---|---|---|
| Protein content | ≥90% (dry basis) | Determined by Kjeldahl or Dumas; varies by grade |
| Moisture | ≤10% | Higher moisture reduces shelf life and promotes clumping |
| Heavy metals | Lead ≤2 mg/kg; arsenic ≤1 mg/kg | Limits vary by jurisdiction; tested by ICP-MS |
| Microbial limits | Total aerobic count ≤10^4 CFU/g | Typical specification for food-grade powders |
| Labeling | Hydrolyzed collagen or collagen peptides | Source animal must be declared in many markets |
Commercial collagen peptides come from bovine hide, porcine skin, fish scales, and fish skin. Each source yields a distinct amino acid profile, including different levels of hydroxyproline and glycine. Marine sources often have lower hydroxyproline content than mammalian sources. Production involves extraction, hydrolysis, filtration, and drying, usually spray drying. The final powder is typically white to off-white and dissolves readily in water. Exact composition and peptide size depend on the raw material and the hydrolysis conditions.
Collagen is a structural protein found in skin, bone, tendon, and cartilage, where it forms a triple helix of three polypeptide chains. The chains contain repeating Gly-X-Y sequences, with proline and hydroxyproline frequently occupying the X and Y positions. Collagen peptides are fragments produced by breaking these long chains through hydrolysis. These fragments vary in length and amino acid composition depending on the source and processing method, so the term covers a range of products rather than a single defined molecule.
Hydrolysis converts native collagen into shorter peptides and improves water solubility. Enzymatic treatment with proteases such as pepsin or alkaline proteases is common, though acid or thermal hydrolysis can also be used. The resulting molecular weight distribution typically ranges from about 2 to 10 kilodaltons. Gelatin is a related product formed by partial hydrolysis, but it retains the ability to gel in water. Collagen peptides undergo further breakdown and generally do not form gels.
Storage and handling of collagen peptides require protection from moisture, heat, and light. The powders are hygroscopic and can absorb water from the air, leading to clumping or microbial growth. Typical storage conditions are a cool, dry place at room temperature or below, in tightly sealed containers. Some manufacturers recommend refrigeration for long-term stability. Solutions prepared from the powder are less stable and should be used promptly or preserved according to validated protocols.
Production of collagen peptides begins with raw materials such as bovine hide, porcine skin, fish scales, or poultry cartilage. The collagen is extracted, often with acid or alkaline treatment, and then subjected to hydrolysis using enzymes like pepsin or alcalase, or chemical agents. Enzymatic hydrolysis is favored for its mild conditions and controllability. The resulting mixture is filtered, concentrated, and dried to yield a powder. Process parameters such as temperature, pH, and enzyme-to-substrate ratio determine the molecular weight profile and yield.
Analytical methods for collagen peptides focus on molecular weight distribution, amino acid composition, and purity. Size exclusion chromatography with UV detection is widely used to estimate molecular weight ranges. High-performance liquid chromatography can quantify hydroxyproline after acid hydrolysis. Mass spectrometry provides detailed sequence information for individual peptides. Other tests include moisture content, ash, heavy metals, and microbial limits. The choice of method depends on the specific quality attribute and the required sensitivity.
Analytical results are method-dependent, so comparisons across studies require caution. Different molecular weight cutoffs, standards, and calculation models can shift reported averages. Hydroxyproline content is sometimes used as a marker for collagen-derived material, but it does not reveal peptide sequence or biological activity. Regulatory status varies by country and intended use, with some markets treating hydrolyzed collagen as a food ingredient and others as a dietary supplement. Open questions include how to standardize potency and verify claimed peptide profiles.
Quality control for hydrolyzed collagen begins with identity testing and raw material traceability. Laboratories may verify protein content by Kjeldahl or combustion methods, and characterize molecular weight distribution using size-exclusion chromatography or gel electrophoresis. Amino acid analysis confirms the presence of glycine, proline, and hydroxyproline in expected proportions. Moisture, ash, and microbial limits are also monitored because powders can absorb water. These tests help distinguish hydrolyzed collagen from gelatin, whey, or plant protein ingredients.
Stability depends on moisture, temperature, and packaging. Dry powders are generally stable for months to years when kept sealed and cool, but heat and humidity can promote clumping, Maillard reactions, and off-flavors. Peptides with lower molecular weight may be more hygroscopic than longer-chain hydrolysates. Light exposure is less critical than moisture control for most commercial powders. Once a container is opened, repeated exposure to air can shorten usable shelf life.
=== Animal model === Research into malignant hyperthermia was limited until the discovery of "porcine stress syndrome" (PSS) in Danish Landrace and other pig breeds selected for muscling, a condition in which stressed pigs develop "pale, soft, exudative" flesh (a manifestation of the effects of malignant hyperthermia) rendering their meat less marketable at slaughter. This "awake triggering" was not observed in humans, and initially cast doubts on the value of the animal model, but subsequently, susceptible humans were discovered to "awake trigger" (develop malignant hyperthermia) in stressful situations. This supported the use of the pig model for research. Pig farmers use halothane cones in swine yards to expose piglets to halothane. Those that die were MH-susceptible, thus saving the farmer the expense of raising a pig whose meat he would not be able to market. This also reduced the use of breeding stock carrying the genes for PSS. The condition in swine is also due to a defect in ryanodine receptors. Gillard et al. discovered the causative mutation in humans only after similar mutations had first been described in pigs. Horses also develop malignant hyperthermia. A causative mutated allele, ryanodine receptor 1 gene (RyR1) at nucleotide C7360G, generating a R2454G amino acid substitution. has been identified in the American Quarter Horse and breeds with Quarter Horse ancestry, inherited as an autosomal dominant. It can be caused by overwork, anesthesia, or stress. In dogs, its inheritance is autosomal recessive.
Abdul Basit, senior associate fellow at the International Centre for Political Violence and Terrorism Research (ICPVTR), stressed that the concern was not the drones' sophistication, but their presence in Pakistan's capital. Taliban drones forced airspace closures and targeted deep within the country, escalating the threat both horizontally and vertically. Hammad Waleed, a research associate at Pakistan's Strategic Vision Institute, stated that while Pakistan's air defense could counter numbered drone projectiles, it would struggle against drone swarms.
The territorial authorities of New Zealand are the country's municipal local government entities, existing alongside the country's regional councils. There are 67 such authorities, including 12 city councils, 53 district councils and 2 sui generis councils (Auckland Council and Chatham Islands Council). Five territorial authorities also have the powers of regional councils, and these are called unitary authorities. Territorial authorities are not subservient to regional councils, and several of them have jurisdictions overlapping multiple regional council areas. Territorial authorities are responsible for the administration of local matters and resources. These include roads, building consents, water supply and sanitation, amongst other responsibilities. Non-unitary territorial authorities are not responsible for broader regional environmental management or public transport, as those are the responsibilities of the regional councils.
It thus seems likely that while δ-opioid agonists can produce respiratory depression at very high doses, at lower doses they have the opposite effect, a fact that may make mixed mu/delta agonists such as DPI-3290 potentially very useful drugs that might be much safer than the μ agonists currently used for pain relief. Many delta agonists may also cause seizures at high doses, although not all delta agonists produce this effect. Of additional interest is the potential for delta agonists to be developed for use as a novel class of antidepressant drugs, following robust evidence of both antidepressant effects and also upregulation of BDNF production in the brain in animal models of depression. These antidepressant effects have been linked to endogenous opioid peptides acting at δ- and μ-opioid receptors, and so can also be produced by enkephalinase inhibitors such as RB-101. However, in human models the data for antidepressant effects remains inconclusive. In the 2008 Phase 2 clinical trial by Astra Zeneca, NCT00759395, 15 patients were treated with the selective delta agonist AZD 2327. The results showed no significant effect on mood suggesting that δ-opioid receptor modulation might not participate in the regulation of mood in humans. However, doses were administered at low doses and the pharmacological data also remains inconclusive. Further trials are required. Another interesting aspect of δ-opioid receptor function is the suggestion of μ/δ-opioid receptor interactions. At the extremes of this suggestion lies the possibility of a μ/δ opioid receptor oligomer.
== Discovery == Islets of Langerhans were first discussed by Paul Langerhans in his medical thesis in 1869. This same year, Édouard Laguesse named them after Langerhans. At first, there was a lot of controversy about what the Islets were made of and what they did. It appeared that all of the cells were the same within the Islet, but were histologically distinct from acini cells. Laguesse discovered that the cells within the Islets of Langerhans contained granules that distinguished them from acini cells. He also determined that these granules were products of the metabolism of the cells in which they were contained. Michael Lane was the one to discover that alpha cells were histologically different than beta cells in 1907. Before the function of alpha cells was discovered, the function of their metabolic product, glucagon, was discovered. The discovery of the function of glucagon coincides with the discovery of the function of insulin. In 1921, Banting and Best were testing pancreatic extracts in dogs that had had their pancreas removed. They discovered that "insulin-induced hypoglycemia was preceded by a transient, rather mild hyperglycemia..." Murlin is credited with the discovery of glucagon because in 1923 they suggested that the early hyperglycemic effect observed by Banting and Best was due to "a contaminant with glucogenic properties that they also proposed to call 'glucagon,' or the mobilizer of glucose". In 1948, Sutherland and de Duve established that alpha cells in the pancreas were the source of glucagon.
Sources: en.wikipedia.org
Complement 3 (C3) through its interaction with factors B and D (adipsin) generates C3a. In the human body, C3a is rapidly cleaved by carboxypeptidase B or carbxyopeptidase N, that remove the carboxyl-terminal arginine to generate C3adesArg. Thus, most of plasmatic C3a is present in C3adesArg form. C3adesArg is more commonly named ASP or acylation-stimulating-protein due to its marked stimulating action on triacylglycerol synthesis in human adipocytes and skin fibroblasts. ASP is also known for its augmentation of glucose transport and inhibiting action on hormone-sensitive lipase. Because of these actions, it is linked to the pathogenesis of obesity, having been demonstrated to be present at increased levels in patients with obesity, diabetes mellitus type 2 and coronary artery disease. ASP lis a ligand for C5L2, a G-protein-coupled receptor. The view of C3a/C3adesArg as an acylation stimulating activity is not universally accepted. The evidence is discussed in a recent review.
In February 2018, The Marshall Project published an investigation reporting that the new label allowed Johnson & Johnson to market Invega Sustenna as a way to keep people out of prison or jail. John Snook, executive director of the Treatment Advocacy Center, described the "stay-out-of-jail" marketing approach as a "depressing commentary" on the state of mental health treatment. Critics noted that the PRIDE study did not compare Invega Sustenna with other long-acting injectable antipsychotics, only with daily oral antipsychotics, and that the reduced rate of incarceration was likely due to improved drug adherence rather than a unique property of paliperidone palmitate. A 2022 review of internal pharmaceutical industry documents, published in the Journal of Correctional Health Care, identified Janssen as one of at least two companies that directly marketed antipsychotics to jails and prisons to increase sales. The review found that marketing strategies included targeted promotions, indirect "educational" advertising, and efforts to influence state formulary advisory boards. Concerns have also been raised about industry influence on the evidence base for long‑acting injectable (LAI) antipsychotics. In a 2024 paper in Accountability in Research, Lisa Cosgrove and colleagues presented a case analysis arguing that systematic reviews comparing LAIs to oral antipsychotics can be "shaped by commercial interests" and that financial conflicts of interest among review authors may "undermine patient‑centered models of recovery and care."
== History == "Enthesis" is rooted in the Ancient Greek word, "ἔνθεσις" or "énthesis," meaning "putting in," or "insertion." This refers to the role of the enthesis as the site of attachment of bones with tendons or ligaments. Relatedly, in muscle terminology, the insertion is the site of attachment at the end with predominant movement or action (opposite of the origin). Thus the words (enthesis and insertion [of muscle]) are proximal in the semantic field, but insertion in reference to muscle can refer to any relevant aspect of the site (i.e., the attachment per se, the bone, the tendon, or the entire area), whereas enthesis refers to the attachment per se and to ligamentous attachments as well as tendinous ones.
the restructuring of websites that causes changes in URLs (e.g. domain.net/pine_tree might be moved to domain.net/tree/pine) relocation of formerly free content to behind a paywall a change in server architecture that results in code such as PHP functioning differently dynamic page content such as search results that changes by design deletion of the target page and/or its content the presence of user-specific information (such as a login name) within the link deliberate blocking by content filters or firewalls the expiration of a domain name registration
{\displaystyle {\begin{aligned}{\frac {D\omega _{i}}{Dt}}&={\frac {\partial \omega _{i}}{\partial t}}+v_{j}{\frac {\partial \omega _{i}}{\partial x_{j}}}\\&=\omega _{j}{\frac {\partial v_{i}}{\partial x_{j}}}-\omega _{i}{\frac {\partial v_{j}}{\partial x_{j}}}+e_{ijk}{\frac {1}{\rho ^{2}}}{\frac {\partial \rho }{\partial x_{j}}}{\frac {\partial p}{\partial x_{k}}}+e_{ijk}{\frac {\partial }{\partial x_{j}}}\left({\frac {1}{\rho }}{\frac {\partial \tau _{km}}{\partial x_{m}}}\right)+e_{ijk}{\frac {\partial B_{k}}{\partial x_{j}}}\end{aligned}}}
Sources: en.wikipedia.org
Size-exclusion chromatography is the standard method, often with refractive index or ultraviolet detection. Calibration uses known protein standards. SDS-PAGE can provide a rough range but is less precise.
No. In most countries they are regulated as food ingredients or dietary supplements. They cannot carry claims to treat or prevent disease.
Dry powder should be kept in sealed containers at ambient temperature, away from moisture and direct sunlight. High humidity can cause clumping and microbial growth. Liquid formulations may require refrigeration.
Common methods include size-exclusion chromatography and mass spectrometry. Amino acid analysis provides composition data but not chain length. Results depend on calibration standards and sample preparation.